Metastatic HER2-Positive Breast Cancer: Innovative Therapeutic Options and Updates for Managed Care

Program Description
The advent of additional HER2-targeted therapies to the armamentarium of breast cancer therapies has contributed to improved outcomes for patients with HER2-positive disease. To provide access to cost-effective treatment for patients, managed care professionals need to be familiar with the clinical data and indications for use of these agents in HER2-positive disease. This activity will delve into nuances among available and emerging agents, as well as how these agents fit within guideline recommendations and affect formulary decisions. The expert faculty will also present strategies managed care professionals can use to develop and evaluate evidence-based oncology clinical pathways to positively impact quality of care while managing costs and factors affecting medication utilization, especially in patients receiving HER2-targeted therapies.

Target Audience: Managed care pharmacists

Type of Activity: Application

Release date: November 3, 2021

Expiration date: November 3, 2022

Time to complete activity: 1.5 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Distinguish HER2-targeted treatment and differences among therapies

• Analyze current guidelines and emerging options for HER2-positive breast cancer

• Employ oncology clinical pathways as a tool to assist in access and resource utilization for HER2-positive breast cancer

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-21-380-H01-P. The activity is available for CE credit through November 3, 2022.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Allison R. Butts, PharmD, BCOP, and Laura R. Bobolts, PharmD, BCOP

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy H. Seung, PharmD, BCOP, FHOPA; Liz Rauh; Susan Pordon; Brianna Winters; and Chloe Taccetta

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.


Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms